The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Another fine and dry day with long sunny spells.
Welsh acts Jamie Miller and Into The Ark have made it to the final of ITV's The Voice UK.
Mind Cymru is calling for specialist mother and baby units to be reinstated in Wales.